Because FSGS can be a secondary risk factor to AS and thin basement membrane disease, FSGS may be a process in the development of AS and GBM related diseases caused by variants in COL4A3/COL4A4 (Zhu et al., 2018). This evidence concerns the gene COL4A3 and focal segmental glomerulosclerosis.